Claviceps, Protoplasts Regeneration, Strain Development, Ergot Alkaloids, Enzymes Three ergoline alkaloids producing Claviceps strains easily formed protoplasts when treated with snail digestive extract ex Helix pomatia. Colonies obtained after regeneration of protoplasts were monitored for alkaloid production. Among the regenerated progeny strains could be iso lated which differ considerably in the quantity of ergolines and the composition of the alkaloid mixture compared with parental strains. Protoplast-derived strains were stable in morphology and alkaloid production for more than four years if the propagation was performed with hyphal fragments. Activities of some alkaloid-specific enzymes e.g. oxygenases and ergotamine syntheta se were studied in various related strains.
Introduction
A number of ergot alkaloids and some semisynthe tic ergolines are therapeutically important agents. For the production of ergot alkaloids fermentation procedures are in use since about two decades be sides the parasitic cultivation of ergot on rye plants. The increasing biotechnological importance of some Claviceps species e.g. Cl. purpurea and Cl. paspali stimulated the search for efficient methods to obtain high-yielding strains. First experiments in this direc tion including mutagenesis followed by subsequent selection were described by Kobel et al. [1] and Kobel and Sanglier [2] . Another approach is the fusion of fungal protoplasts to obtain hybrid strains. Suitable techniques for preparing protoplasts from ergot fungi were at first described by Spalla et al. [3] and independently by Stahl et al. [4] , Methods for intra-specific and inter-specific fusions of protoplasts derived from alkaloid-producing ergot strains for strain improvement were introduced by Spalla and Marnati [5, 6 ].
We used protoplasts for physiological and biochemical studies with respect to ergot alkaloid formation [7, 8 ] . Furthermore during the past ten years several thousand of colonies which we have obtained after reversion of protoplasts were moni tored for alkaloid synthesis. The present report de scribes the properties of some strains derived from Claviceps protoplasts without mutagenesis.
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Material and Methods

Organisms
The work was carried out with submerged culti vated mycelia. As parent strains were used: Pepty 695/S and JAP 471/1 (Claviceps purpurea), and SD 58/ 78 (Claviceps fusiformis). The alkaloid spectra of the parent strains and their progeny are given in Fig. 1 .
Culture technique
The stock cultures were maintained on asparagine/ sucrose agar. The strains were grown in submerged cultures at 24 °C at 240 rpm on a VEB Fanal rotary shaker. For preparing the inoculum mycelium of 4 weeks old agar slants were used. The 7 day old preculture my celium was transferred into 500 ml flat bottom flasks containing 100 ml culture-broth. The inoculum rate amounted to 1:10. As preculture medium NL 720 was used except for strains JAP 471/1 and MUT 170/1 which were grown in a sucrose/skim milk medium NL 849 [9] . Alkaloid production was achieved with strains Pepty 695/S and SD 58/78 and their progeny in medium NL 720 and sometimes with SD 58/78 in NL 614. The strains JA P 471/1 and MUT 170/1 were culti vated in NL 833 for alkaloid synthesis.
Protoplast formation and regeneration
For preparing protoplasts the method of Stahl [4] was employed. Mycelium from 3-to 4-day-old shake cultures was harvested on a coarse sintered glass fun nel and washed several times with a small volume of 0.7 m KC1 solution. Following the incubation with a self-prepared snail digestive extract the mixture of protoplasts and mycelial fragments was centrifuged at 3000 rpm for 15 min. The pellet was washed twice with 0.7 m KC1 solution and finally taken up with the salt solution and filtered through cotton. The proto plast suspension was immediately used for plating.
To carry out the regeneration of intact cells, proto plasts were plated onto agar plates containing a medium composed of (g-T1): sucrose 1 0 0 ; am monium citrate 10; C a(N 03 ) 2 1; M gS04 -7H20 0.3; K H 2 P 0 4 0.250; KC1 0.1; agar 30 at a pH of 5.5.
Enzyme assays
Lyophilized mycelia were used to prepare the en zyme extracts. Chanoclavine-I-cyclase: Lyophilized mycelium from a 4-day-old culture was ruptured by grinding with dry ice in a mortar and suspended in 0.1 m Tris-HCl buffer (pH 7. Tris-HCl buffer (pH 7.8) in a final volume of 250 nlIncubations were carried out for 2 h at 27 °C with shaking at 240 rpm. The reaction products were purified by TLC. In the case of "agroclavine hy droxylase" non-labelled elymoclavine was added as carrier and the alkaloids separated on silica gel PF254 (Merck). Solvent systems, I: CH Cl3/MeOH (8:2, v/ v), II: CH Cl3/M eOH/AcOH (7:3:0.1, v/v). Aliquots of the twice purified elymoclavine were used for quantitation and counting of radioactivity. The reac tion product of "elymoclavine hydroxylase" was separated after adding of non-labelled lysergic acid in solvent III: C H C l3/MeOH/NH4O H conc (7:3:0.5, v/v). After elution with 1% K O H in M eOH the radioactivity was counted. The counts of controls containing boiled protein extracts and incubated without N A D P H were substracted. The enzyme activities were expressed as nmol elymoclavine or lysergic acid per mg protein per 2 h.
Ergotamine synthetase: The preparation of cellfree extracts and purification of ergotamine synthe tase were performed as described previously [1 1 ]. The cell-free extract was fractionated by ammonium sulfate precipitation. The precipitate was chromato graphed on a Sepharose 4B column, and the active fractions subsequently applied onto a DEAESepharose CL-6 B column. After elution with a linear potassium phosphate gradient were the active fractions pooled and used for the enzyme assay.
The reaction mixture contained in 0.7 ml: 41.2 pmol of L-[ring 2,6-3H] phenylalanine (2 nCi), 0.1 nmol of each L-alanine and L-proline, 0.05 nmol of each agroclavine and elymoclavine, 1 nmol of ATP (pH 7.8), 7 nmol Mg2+, 300 nl Tris-HCl buffer (pH 7.8) and enzyme solution containing 100-200 ng protein. The mixture was incubated for 1 h at 27 °C on a shaker at 240 rpm. The enzymatically formed ergotamine was assayed according to [8 , 1 1 ].
Analytical procedures
Total alkaloid determination was carried out colorimetrically [12] using van Urk's reagent. The opti cal density was determined at 580 nm. The quantity of alkaloids were calculated according to a standard curve using elymoclavine for clavine-producing strains or the appropriate peptide alkaloids for ergopeptine producers.
For identification the alkaloids were chromato graphed or rechromatographed using TLC (silica gel PF254) in different solvent systems [13, 14] . The chromatographically pure alkaloids were used for recording mass spectra. Furthermore ergopeptines were identified by comparing HPLC retention times with authentic samples. This was carried out with a HP 1090 Liquid Chromatograph (Hewlett Packard) on a Separon SIX C-18 column. Alkaloids were eluted with methanol/3% triethylamine (1:1, v/v) and detected by U V absorption at 312 nm.
The protein content of enzyme preparation was estimated by the method of Bradford [15] .
Results and Discussion
The genealogy of various Claviceps strains is given in Fig. 1 . During a screening program we tested sin gle colonies derived from hyphal fragments of the Claviceps purpurea strain Pepty 695/S [16] . One iso late showed no changes in morphology and pigmen tation compared with the parent strain but failed to produce lysergic acid derivatives: strain Pepty 695/ch accumulates only secoclavines (Fig. 2 ). An isolate with a similar alkaloid pattern as Pepty 695/ch was obtained from regenerated protoplasts of the Claviceps fusiformis strain SD 58/78, which synthesi zes agroclavine and elymoclavine but never lysergic acid derivatives.
After reversion of protoplasts of the secoclavine producer Pepty 695/ch to the normal cell form an isolate was found which differed remarkably from the parent. The total alkaloid yield was about six times higher and as endproducts of the ergoline path way tetracyclic clavines were accumulated instead of chanoclavine-I (strain Pepty 695/ch-I). Three isolates with similar properties regarding alkaloid formation were obtained after protoplasting and regeneration of the ergotoxine producer Pepty 695/S. After rever sion of protoplasts of this particular strain one isolate was found with a reduced total alkaloid yield. Re markably in low quantities ergotoxine alkaloids were present in the alkaloid mixture. Presumably this strain is a revertant and was designated as Pepty 695/ ch-I/3R. An isolate of an ergopeptine strain JA P 470/ I, which we obtained after protoplasting produced only ergosine instead of ergotamine. This means in the peptide portion of ergotamine phenylalanine was replaced by leucine in strain MUT 170/1. It is noteworthy that all protoplast-derived strains were stable for more than 4 years with regard to al kaloid production and the alkaloid pattern if the transfers were done with hyphal fragments.
Strain Pepty 695/ch is an "alkaloid-blocked mu tant" . After feeding of appropriate intermediates (mutasynthesis) the mutant produces the normal alkaloid spectrum of the parent strain. Surprisingly after administration of agroclavine ergosine is addi tionally synthesized besides the ergotoxines [13] . It could be demonstrated that in this strain the activity of the enzyme converting I I -» IV is drastically re duced compared with the ergotoxine-producing strain Pepty 695/S [16] . This prompted us to look for several alkaloid-specific enzymes in the isolated ergot strains. In strain Pepty 695/ch-I which is derived from protoplasts of the secoclavines accumulating blocked mutant chanoclavine-I-cyclase activity is fully re stored: the conversion rate of chanoclavine-I to ag roclavine amounted to 50% like in other tetracyclic ergolines producing Claviceps strains.
Oxygenases are involved in the conversion of agro clavine to lysergic acid. Apparently the formation of lysergic acid proceeds via paspalic acid [17] . The time-course of two oxygenases of strain Pepty 695/S is shown in Fig. 3 . In the microsomal fraction both oxygenases are present. Therefore a relative low amount of V is accumulated if agroclavine is used as substrate. The synthesized elymoclavine is in turn converted to lysergic acid as it is seen in the curve agroclavine -» lysergic acid. We assume that the ac tivities of both agroclavine 17-monooxygenase and elymoclavine 17-monooxygenase are roughly equal in peptide-alkaloids producing strains (Table) . This means the "cyclol-synthetase" responsible for the formation of the peptide is partially active com pared with strain Pepty 695/S (Fig. 1) . Furthermore one may conclude that the "cyclol synthetase" , should be also present but "silent" in Pepty 695/ch-I/3 and Pepty 695/ch-I. Using the purification method [1 1 ] we could demonstrate the presence of ergotamine synthetase in cell free extracts of both clavines accumulating strains of the Pepty-series. The specific activity amounted to 2 .1 x l0 6 dpm ergotamine • mg-1 protein-h-1. Furthermore we di luted the enzymatically formed ergotamine with non labelled alkaloid and recrystallized the mixture to constant specific radioactivity. In control experi ments using boiled enzyme extract no ergotamine was formed. It should be emphasized that er gotamine is not synthesized under normal fermenta tion conditions in strain Pepty 695/S. However it is well known that the cyclol synthetases in various Claviceps strains possess a rather broad specificity [13, 18, 19] and that the alkaloid spectrum can be changed by mutation [2] , The reason why the "cyclol synthetase" is not operative in strains Pepty 695/ch-I and Pepty 695/ch-I/3 is not clarified but might be due to the scarcity of the appropriate ergoline moiety e.g. lysergic acid within the cells. Additionally we found also that an enzyme system catalyzing the incorporation of L-phenylalanine into ergotamine is present in strains Pepty 695/ch and Pepty 695/ch-I/3R.
Time OF incubation (inhours)
At present there is no plausible explanation which mechanisms are responsible for suppression or resto ration of enzyme activities involved in alkaloid syn thesis in related ergot strains e.g. the Pepty series.
Genetic instabilities associated with protoplast techniques and their influence on secondary metabo lite formation were first observed in Streptomycetes. Formation and regeneration of protoplasts caused the loss of plasmid D N A in different Streptomyces species [20, 21] . In 5. fradiae protoplasting and re generation was associated with deletion of tylosin biosynthetic genes and several antibiotic resistance genes [22, 23] . Furumai et al. [21] isolated a spon taneous mutant 18 a from S. kasugaensis exhibiting a pleiotropic effect such as loss of aerial mycelium formation, aureothricin production and of citrullin biosynthesis. Regeneration of 18a protoplasts caused a reversion of pleiotropic mutation with high fre quency. Ikeda et al. [24] observed besides variations in morphology that antibiotic productivities of the regenerated progeny of S. fradiae and S. ambofaciens were drastically changed. One strain from S. fradiae obtained after two rounds of protoplast regeneration produced about three times as much as the parent strain. Enzymes involved in antibiotic syn thesis were not studied in Streptomyces strains ob tained after protoplast regeneration. Keller [25] de scribed an efficient method for mutation and selec tion by using Claviceps purpurea protoplasts. In con trols without mutagenic treatment a high portion of colonies with altered morphology and a lowered level of alkaloid production were detected after pro toplast regeneration. This event was never observed when hyphal fragments were streaked on solid medium. Interestingly plasmids have been also found in some wild strains of ergot [26] . Their role in er goline biosynthesis has-not yet been elucidated. Further research is necessary for a better under standing of the genetics of alkaloid formation and the metabolic changes associated with protoplast forma tion and regeneration in Claviceps.
